Profile
Andrew M.
Sadosky worked as a Director at Primus Therapeutics, Inc. from 2010 to 2011.
He holds an MBA from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.
Former positions of Andrew M. Sadosky
| Companies | Position | End |
|---|---|---|
Primus Therapeutics, Inc.
 Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Director/Board Member | 31/12/2010 |
Training of Andrew M. Sadosky
| University of Pennsylvania | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Health Technology |
- Stock Market
- Insiders
- Andrew M. Sadosky
